157 related articles for article (PubMed ID: 35327577)
1. TLR4 Expression in Ex-Lichenoid Lesions-Oral Squamous Cell Carcinomas and Its Surrounding Epithelium: The Role of Tumor Inflammatory Microenvironment.
Visioli F; Nunes JS; Pedicillo MC; Leonardi R; Santoro A; Zannoni GF; Aquino G; Cerrone M; Cantile M; Losito NS; Rodolico V; Campisi G; Colella G; De Stefano IS; Ramunno MA; Pizzulli C; Visconti M; Lo Muzio L; Pannone G
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327577
[TBL] [Abstract][Full Text] [Related]
2. Expression of Toll-like receptors in oral squamous cell carcinoma.
Rusanen P; Marttila E; Amatya SB; Hagström J; Uittamo J; Reunanen J; Rautemaa-Richardson R; Salo T
PLoS One; 2024; 19(4):e0300437. PubMed ID: 38593176
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.
Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P
Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of toll-like receptor 4 and nuclear factor-κBp65 in oral squamous cell carcinoma patients.
Yang J; Liu D; Khatri KS; Wang J; Zhang G; Meng C; Guan J
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):753-764.e1. PubMed ID: 27727111
[TBL] [Abstract][Full Text] [Related]
5. Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: an immunohistochemical and clinical correlation analysis.
Ren WH; Zhang LM; Liu HQ; Gao L; Chen C; Qiang C; Wang XL; Liu CY; Li SM; Huang C; Qi H; Zhi KQ
Med Oncol; 2014 Aug; 31(8):120. PubMed ID: 25027624
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment.
Han S; Xu W; Wang Z; Qi X; Wang Y; Ni Y; Shen H; Hu Q; Han W
Oncotarget; 2016 Jun; 7(25):37773-37789. PubMed ID: 27191981
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.
Omar AA; Korvala J; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Sorsa T; Hagström J; Salo T
J Oral Pathol Med; 2015 Apr; 44(4):258-65. PubMed ID: 25047824
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
[TBL] [Abstract][Full Text] [Related]
9. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of T Helper Cells by Tumor Microenvironment in Oral Cancer Is Associated With CCR8 Expression and Rapid Membrane Vitamin D Signaling Pathway.
Fraga M; Yáñez M; Sherman M; Llerena F; Hernandez M; Nourdin G; Álvarez F; Urrizola J; Rivera C; Lamperti L; Nova L; Castro S; Zambrano O; Cifuentes A; Campos L; Moya S; Pastor J; Nuñez M; Gatica J; Figueroa J; Zúñiga F; Salomón C; Cerda G; Puentes R; Labarca G; Vidal M; McGregor R; Nova-Lamperti E
Front Immunol; 2021; 12():643298. PubMed ID: 34025655
[TBL] [Abstract][Full Text] [Related]
11. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
[TBL] [Abstract][Full Text] [Related]
12. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
13. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway.
Pang X; Wang SS; Zhang M; Jiang J; Fan HY; Wu JS; Wang HF; Liang XH; Tang YL
Cancer Immunol Immunother; 2021 Apr; 70(4):1015-1029. PubMed ID: 33104837
[TBL] [Abstract][Full Text] [Related]
14. HSP70 induces TLR4 signaling in oral squamous cell carcinoma: an immunohistochemical study.
Nair S; Kotrashetti VS; Nayak R; Bhat K; Somannavar P; Hosmani J
J Cancer Res Ther; 2013; 9(4):624-9. PubMed ID: 24518707
[TBL] [Abstract][Full Text] [Related]
15. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
16. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Priyadarshini M; Maji S; Samal SK; Rath R; Li J; Das SK; Emdad L; Kundu CN; Fisher PB; Dash R
Life Sci; 2021 Dec; 287():120141. PubMed ID: 34774620
[TBL] [Abstract][Full Text] [Related]
17. The Role of Sonic Hedgehog Signaling in the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
Takabatake K; Shimo T; Murakami J; Anqi C; Kawai H; Yoshida S; Wathone Oo M; Haruka O; Sukegawa S; Tsujigiwa H; Nakano K; Nagatsuka H
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744214
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy upregulated immune checkpoints contribute to the development of second primary OSCC.
Wang L; Wang S; Zhang J; Peng J; Cheng B; Li H; Hu Q
Oral Dis; 2024 May; 30(4):2188-2201. PubMed ID: 37213085
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
20. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
